Headlands Technologies LLC Axsome Therapeutics, Inc. Transaction History

Headlands Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$69.39 - $97.64 $1,665 - $2,343	24 Added 30.77%	102 $8,000
Q4 2023 Feb 02, 2024	SELL	$57.42 - $83.61 $17,915 - $26,086	-312 Reduced 80.0%	78 $6,000
Q3 2023 Nov 09, 2023	BUY	$69.25 - $82.21 $4,501 - $5,343	65 Added 20.0%	390 $27,000
Q2 2023 Aug 03, 2023	BUY	$58.41 - $90.35 $18,983 - $29,363	325 New	325 $23,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Headlands Technologies LLC with notifications on news.